claire butler

Respiratory & Difficult Asthma doc. Views expressed my own

[PCRS @PCRSUK]

A marked rise in hospital admission rates for asthma among young people occurs during September and 'week 38' specifically. This is also known as the 'September Surge'.

Take some time to prepare ahead of the surge with our clinical resources on #asthma🔎 https://t.co/WeZt1IGr9c

[claire butler @cbut129]

@deux_knees Well done superstar x

[ThoraxBMJ @ThoraxBMJ]

QRISK3 underestimates the risk of cardiovascular events in patients with COPD.
https://t.co/iYYCEm6ubA @mo_safavi

[John Hurst @ProfHurst]

Breathless and heart broken in COPD, or why it’s important to be as interested in the blood pressure as the oxygen saturation.

https://t.co/TIwzZ3sEkJ

[Respirology @RespirologyAPSR]

🌏Respirology
Home oxygen guidelines: We do not know enough about LTOT- an expert view on the topic and linked to a recent TSANZ Clinical Practice Guideline in #Respirology

#FreeAccess & #OpenAccess
https://t.co/DuKM9qHtbb linked to https://t.co/9Azg0mSr1K

[claire butler @cbut129]

@DublinAirport @AirCanada @alib67390152

[claire butler @cbut129]

@rosie_hogg @OBsleepmerchant I’d always call you @rosie_hogg

[claire butler @cbut129]

@ehega1804 The Respiratory take doesn’t know it’s spring either

[claire butler @cbut129]

@timnx44 @NIJDC @bbcradioulster @BMA_NI @BMA_JuniorDocs @Doctors_Vote Well done Tim

[Vanessa McDonald @nessmcd]

‘I can’t get air in’
We report the experience of living with #asthma and #vcd / #ilo

⁦@maj_ele⁩ ⁦@nessiewil⁩ ⁦@AnneAldrid87576⁩ ⁦@traitsCRE⁩ ⁦@HMRIAustralia⁩ ⁦@Uni_Newcastle⁩ https://t.co/gjwzTU2BJU

[claire butler @cbut129]

@rosie_hogg @Assoc_Anaes @Anaes_Trainees @COAIrl @_NIMDTA @AnaesTrainees @clairenestor1 @davejohnston24 @ProfEllenO @mmonaghan07 @ryan_howle @aislinn_sherwin @ObsAnaesNetwork @RCSICritCare @CritCareReviews @NIRASociety Can I come!!

[ERS publications @ERSpublications]

European Respiratory Review: Smoking in people who are otherwise eligible for home oxygen therapy poses a clinical challenge, where management should include a risk–benefit evaluation and medical, practical, legal and ethical considerations. https://t.co/4lmAQDMuoa

[ERS publications @ERSpublications]

ERJ: After initial therapy termination, resumption and continuation of CPAP therapy was associated with lower all-cause mortality risk than therapy resumption followed by a second termination. This highlights the value of offering a second CPAP trial. https://t.co/GnfD5aMI1u

[James D Chalmers @ProfJDChalmers]

New paper!
How effective is Pseudomonas eradication treatment in people with bronchiectasis and new isolation of PA?
Answer: 40% will clear PA at 1 year.
Much more effective (48% vs 27%) if you include an inhaled antibiotic
Limitations: observational data only. We need RCTs

[Alfredo Pachas @AlfredoPachasMD]

🔥🔥Applying the treatable traits approach in bronchiectasis-A scoping review of traits, measurements and treatments

@ProfJDChalmers @EvaPolverino @AlibertiStefano @OSibila @FionaMosgrove
@TobWel @Beika_Physio @MichalShteinbe1 @Shoemelia @nessmcd

➡️https://t.co/f18kN4A5Y9

[Don Sin @donsin4]

Protect our kids from #vaping. They are #cigarettes disguised in new wine skin.

[Llinos Jones @drllinos]

Really helpful to have everything in one place- thanks to the Respiratory Futures team for all their work on this!

[ATS Blue Journal @ATSBlueEditor]

Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease

🔗 https://t.co/f2fpFbTZXj

[Don Sin @donsin4]

Even more relevant today now that we will have a #biologic therapy available for patients with #COPD in the near future.

[claire butler @cbut129]

@ciaran_mmooney Who gets the fancy striped one?